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Abstract 11 
The glymphatics system describes a CSF-mediated clearance pathway for the removal of potentially 12 
harmful molecules, such as amyloid beta, from the brain. As such, its components may represent 13 
new therapeutic targets to alleviate aberrant protein accumulation that defines the most prevalent 14 
neurodegenerative conditions.  Currently, however, the absence of any non-invasive measurement 15 
technique prohibits detailed understanding of glymphatic function in the human brain and in turn, 16 
it’s role in pathology.  Here, we present the first non-invasive technique for the assessment of 17 
glymphatic inflow by using an ultra-long echo time, low b-value, multi-direction diffusion weighted 18 
MRI sequence to assess perivascular fluid movement (which represents a critical component of the 19 
glymphatic pathway) in the rat brain.   This novel, quantitative and non-invasive approach may 20 
represent a valuable biomarker of CSF-mediated brain clearance, working towards the clinical need 21 
for reliable and early diagnostic indicators of neurodegenerative conditions such as Alzheimer’s 22 
disease.  23 
 24 
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 30 
Introduction 31 
The recent identification of the glymphatic system and the dural lymphatic network provide exciting 32 
new perspectives on waste clearance mechanisms within the central nervous system (CNS)1,2.  33 
According to the glymphatics hypothesis, cerebrospinal fluid (CSF) crosses from the subarachnoid 34 
space into the periarterial space where it swiftly flows towards the brain tissue. Fluid then passes 35 
into the parenchyma from the perivascular space, a transition mediated by aquaporin-4 (AQP4) 36 
channels that reside on the end feet of astrocytes. This periarterial inflow creates a convective flux 37 
of fluid across the parenchyma that exits via perivenous channels, carrying with it ‘waste products’ 38 
of brain metabolism. As such, the glymphatic pathway has been proposed to function as a ‘cleaning 39 
system’ of the brain. The exchange of CSF with interstitial fluid (ISF) is an established mechanism 40 
underlying the clearance of amyloid beta (Aβ), recognised as a leading molecular candidate to 41 
initiate Alzheimer’s disease (AD) 2-7.   42 
Despite evidence that aspects of the glymphatic pathway are preserved across species8-10, key 43 
questions remain on the anatomy and function in the human brain and to what extent it contributes 44 
to pathology. Currently, however, these questions cannot be answered because there are no non-45 
invasive techniques for assessment.  The development of non-invasive methods to image CSF-46 
mediated brain clearance pathways, such as the glymphatic system, would enable repeated and 47 
practical measurement to investigate this system in the human brain and the intact animal skull.  48 
This, in turn, may help fully characterise impairment of CSF-mediated clearance pathways with age11, 49 
as well as the contribution to Aβ accumulation in AD. Ultimately, such methods could address the 50 
pressing clinical need for reliable and early biomarkers of AD, by identifying patients at risk of Aβ 51 
accumulation due to failing clearance mechanisms.   52 
The perivascular space is a fluid filled compartment that surrounds selected blood vessels in the 53 
brain12.  Perivascular channels form a central component of the glymphatic pathway that is said to 54 
drive rapid CSF-ISF exchange.   Although the precise routes and fluid dynamics that underlie CSF-ISF 55 
exchange remain controversial 13-16, several independent groups have identified perivascular 56 
channels as central to this pathway2,17-19. As such, the perivascular space represents a promising 57 
target for non-invasive imaging biomarkers of CSF-ISF exchange. To date, perivascular function has 58 
been studied using only invasive methods: ex-vivo microscopy17 , two-photon imaging2 and contrast-59 
enhanced MRI following intra-cranial/lumbar injection20,21. In this work we introduce the first non-60 
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invasive method for the assessment of perivascular function using contrast-free MRI, and 61 
demonstrate use of the method in the rodent brain. 62 
Despite recognition that the perivascular space facilitates CSF-ISF exchange, the nature of fluid 63 
movement within this channel is yet to be unambiguously determined. Broadly, the glymphatics 64 
hypothesis describes perivascular fluid movement as possessing coherent, bulk flow2.  However, this 65 
has been questioned by other studies which propose that the fast distribution of CSF-tracers along 66 
the perivascular space can be explained by rapid dispersion of fluid/tracers via mechanical 67 
pulsations, with little bulk flow14,22.  Given the current uncertainty, when considering non-invasive 68 
MRI techniques for assessment, diffusion MRI represents a prime candidate for initial application 69 
owing to its established sensitivity to water dispersion, together with evidence of sensitivity to bulk 70 
flow (non-plug e.g. laminar flow) from prior studies of the cerebral vasculature23. That is, irrespective 71 
of whether perivascular fluid movement is dominated by bulk flow or rapid dispersion with little bulk 72 
flow, diffusion MRI sequences, if appropriately tuned, should yield sensitive and quantitative 73 
correlates of fluid movement, albeit non-specific to flow coherence.  74 
In this study, we apply ultra-long echo time (TE), diffusion weighted MRI sequences to assess fluid 75 
movement within perivascular channels surrounding the middle cerebral artery (MCA) of the healthy 76 
rat brain. In addition, given evidence that cerebral arterial pulsation is a key mechanism that drives 77 
PVS fluid movement19,24, we investigate the dependence of the technique on vascular pulsatility 78 
through cardiac gating and modulation by the adrenoceptor agonist, dobutamine. This technique 79 
represents the first non-invasive biomarker of perivascular action, working towards new 80 
translational techniques to assess CSF mediated brain clearance pathways and their role in disease.     81 
Results  82 
Non-Invasive Imaging of Perivascular Channels  83 
The ultra-long TE MRI sequence presented here is designed to attenuate the measured signal from 84 
the blood and parenchyma that immediately surround the perivascular space in order to minimise 85 
partial volume effects, which represent a potential confounder for assessment by MRI given the 86 
small size of this compartment. Figure 1A shows a b0 image of the axial slice through the ventral 87 
aspect of the rat brain.  The subarachnoid CSF that bathes the Circle of Willis (CoW) can be clearly 88 
observed, with marked contrast between the blood vessels within the CoW and surrounding CSF.  89 
Bright tracts appear either side of both MCA branches (Figure 1A) which, due to the ultra-long echo 90 
time, must derive from fluid filled compartments of similar composition to the CSF in the 91 
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subarachnoid space. This observation, together with the characteristic morphology that runs 92 
alongside and parallel to the MCA, is consistent with the description of the perivascular space as a 93 
fluid filled compartment that surrounds major blood vessels feeding the brain12. Indeed, the location 94 
of this compartment is highly consistent with direct assessment from a previous study (Figure 1B, 95 
adapted from Lochhead et al.,18). 96 
The precise definition of the perivascular (and ‘paravascular’) space is somewhat unclear, as 97 
highlighted in a number of recent articles14,15,25.   Whether the fluid filled tracts around the MCA that 98 
we observe (Figure 1 A) occupy a physically and functionally distinct ‘paravascular’ space as 99 
described by Iliff et al.,2 forms a more continuous pathway with subarachnoid CSF as described by 100 
Bedussi et al.25, or are well described by a perivascular space as proposed by Lochhead et al.,18 101 
remains unknown. Irrespective of the precise anatomical bordering of the fluid filled tracts identified 102 
in this work, and despite these semantic differences, all the aforementioned studies have 103 
highlighted the movement of fluid that surrounds subarachnoid arteries as a key site of CSF-tracer 104 
inflow towards the parenchyma. Hence non-invasive assessment of fluid movement within this 105 
compartment represents a meaningful measure of CSF-ISF exchange pathway function.  106 
Assessment of Fluid Movement using Multi-Direction Diffusion Weighted Imaging  107 
Application of a motion probing gradient (MPG) along the principle direction of the perivascular 108 
tracts located around the MCA was observed to markedly attenuate the signal from these tracts 109 
relative to when the MPG was applied perpendicular to their principle orientation (Figure 2 A). 110 
Accordingly, across the 10 subjects, within the right perivascular space, the pseudo-diffusion 111 
coefficient (D*) parallel to PVS orientation was significantly greater than D* in either perpendicular 112 
direction (p<0.01 respectively). In a similar fashion, D* (parallel to principle direction of left PVS) was 113 
significantly greater than D* in either perpendicular direction [p<0.01]. (Figure 2 B).  These data 114 
demonstrate that the MRI sequence employed here can detect the directional dependence of fluid 115 
movement within the perivascular space (the principal directionality of which is parallel to their 116 
orientation), which verifies that they are sensitised to the movement of fluid within this 117 
compartment.  Within the CSF in the subarachnoid space, it was observed that D* when the MPGs 118 
were applied in the in-plane orientation (i.e. parallel to the left or right branch of the MCA) were 119 
both significantly greater than D* in the through plane orientation [p<0.01]. This is consistent with 120 
the known direction of CSF movement in the rostral-caudal direction within this region from prior 121 
invasive studies20,26.   122 
 123 
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Diffusion Tensor Imaging of CSF/Perivascular Fluid Movement 124 
Having verified the sensitivity of the MRI sequence to fluid movement within the perivascular and 125 
subarachnoid space, MPGs were then applied in six different directions to generate a pseudo 126 
diffusion tensor image that reflects the directionality and magnitude of subarachnoid CSF and 127 
perivascular fluid movement.  128 
Figure 3 illustrates that, for the subarachnoid space ROI, the mean D* tensor ellipsoid (n=6) was well 129 
aligned with the known principle direction of CSF movement (caudal-rostral, observed in several 130 
invasive studies of the rodent brain20,26). Likewise, Figure 3 illustrates that the principle direction of 131 
the mean D* tensor of the left and right perivascular space, respectively, was aligned with the 132 
orientation of the respective branch of the MCA.  The D* tensors for each of the individual animals 133 
are shown in Figure 2- figure supplement 1, which show reasonable consistency with the 134 
directionality of the mean tensors shown in Figure 3. The magnitude of the D* tensors within this 135 
region were markedly reduced post-mortem, which demonstrates that a large component of the D* 136 
measurements reflects fluid movement driven by physiological perturbations such as cardiac and 137 
respiratory pulsation and secretion from the choroid plexus (Figure 3 – figure supplement 1). This 138 
may also partially reflect the reported collapse of the PVS post mortem [1] (indeed visual inspection 139 
of the b0 images indicates a reduction in signal intensity within this region [data not shown]).  140 
Fractional anisotropy (SEM) within the right and left perivascular space and the subarachnoid space 141 
was 0.44 (±0.04), 0.36 (±0.04) and 0.6 (±0.02) respectively with mean diffusivity (SEM) calculated to 142 
be 0.0042 (±0.0003), 0.0052 (±0.0003), 0.0065 (±0.0007) mm2/s. Figure 3E shows a map of pseudo 143 
diffusion tensors for a single subject. The principal direction of the D* tensors in the perivascular 144 
tracts that surround the left and right MCA respectively can be seen to run parallel to the orientation 145 
of the MCA. Likewise, the principal orientation of the individual voxel D* tensors can be seen to run 146 
rostral-caudal in the mid-section of the CoW.  147 
Cerebral Arterial Pulsation Drives Non-invasive Measures of Perivascular Fluid Movement 148 
Previous studies have identified cerebral vascular pulsation to play a prominent role in perivascular 149 
fluid propulsion. To investigate this mechanism, MRI data were captured during both cerebral 150 
arterial pulsation and diastole using ECG gating with variable delays to image capture (36 ms and 151 
116 ms from the r-wave to the centre of ‘diffusion’ weighting respectively). The results are shown in 152 
Figure 4, where a striking and highly directional dependence of D* on cerebral vascular pulsation 153 
was observed in the PVS [Figure 4].  D* in the PVS was ~ 300% greater during arterial pulsation 154 
relative to diastole when motion probing gradients were applied parallel to the principle orientation 155 
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(p<0.01). We recorded a more moderate dependence (p=0.1) on the r-wave delay within the CSF ROI 156 
at the mid-section of the CoW (although visual inspection of the D* maps suggests that other regions 157 
within the subarachnoid CSF appeared to show greater changes with the r-wave delay). Minimal 158 
dependence of the D* measures on the r-wave delay was observed in the 3rd ventricle (p = 0.2).   159 
Administration of the adrenoceptor agonist, dobutamine, increased heart rate from (354 ± 8 to 519 160 
±17 bpm).  A 65% increase in D* along PV channels was recorded (p<0.01) following dobutamine 161 
with comparatively little change after vehicle (Figure 4 C).  No significant changes were observed in 162 
the subarachnoid space ROI at the mid-section of the CoW following dobutamine (p=0.39, although 163 
visual inspection of the data suggests other regions within the subarachnoid CSF did show marked 164 
increases in D*).  Dobutamine had minimal effect on D* within the 3rd ventricle (p=0.30).  165 
Together these data are concordant with previous invasive measures demonstrating that 166 
perivascular fluid movement is driven by cerebral vascular pulsation and that we are now able to 167 
capture this mechanistic dependence non-invasively using the techniques introduced here.  168 
Discussion 169 
In this study, we introduce a novel MRI method to measure a distinct feature of brain physiology 170 
that, to date, has only be assessed using invasive methods – the movement of fluid in the 171 
perivascular space.  The perivascular space serves as a preferential pathway for CSF-ISF exchange, an 172 
important mechanism supporting the clearance of potentially harmful molecules, such as Aβ, from 173 
the CNS.  This non-invasive and translational method may have utility in AD research given evidence 174 
that Aβ accumulation (in late stage, sporadic AD) occurs not because of increased Aβ production but 175 
because of decreased rates of Aβ clearance27.  Thus, this technique may expedite greater 176 
understanding of how Aβ clearance mechanisms become impaired with ageing11 and in turn reveal a 177 
new window in early AD pathogenesis in which to target future diagnostic and treatment strategies. 178 
The technique may have broader utility to a range of neurological conditions given reported 179 
associations between glymphatic function in, for example, stroke28 and traumatic brain injury29.   180 
The precise mechanisms that underlie CSF-ISF exchange are yet to be fully defined and this remains 181 
an active area of research.  Accumulative evidence, however, has established cerebral vascular 182 
pulsation as an important mechanism underlying perivascular fluid movement19,24. Here, we have 183 
captured the action of cerebral arterial pulsation to drive perivascular fluid movement using non-184 
invasive techniques (Figure 4). The measured D* showed a remarkable dependence on vascular 185 
pulsation with a ~300% increase recorded during arterial pulsation relative to diastole (Figure 4). 186 
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Moreover, D* (non-gated) was found to markedly increase following adrenoceptor agonist, 187 
dobutamine.  The non-invasive nature of this technique may enable future studies to investigate the 188 
mechanistic link between vascular pulsatility and PVS fluid movement in the healthy human brain, 189 
and its modulation by pathology as well as novel therapy.  190 
In this study, D* estimates were captured using a b0 image and then with motion probing gradients 191 
applied at a single b-value, in different directions. Future studies may wish to examine the behaviour 192 
of the PVS signal over a greater range of b-values (and different values of δ and Δ) to examine 193 
whether, in combination with more advanced signal modelling, this may reveal more detailed insight 194 
into PVS fluid movement.  Of note,  a previous study aimed to correlate MRI measures of water 195 
diffusivity from the PVS to AD severity30. However, this earlier work presents limited evidence as to 196 
the contribution of the perivascular space to the measured MRI signal and hence that the 197 
parameters extracted from their measurements provide meaningful correlates of PVS fluid 198 
movement. 199 
The expression of AQP4 appears to be mechanistically important in CSF-ISF exchange16,31. However, 200 
although genetic deletion of AQP4 was found to markedly decrease rates of small molecular weight 201 
tracer inflow from the CSF into the brain, it did not appear to affect the movement of tracers along 202 
para-arterial channels2. Thus, by extension, as the technique here is targeted to PVS fluid movement, 203 
it may not be sensitive to AQP4 related modulation of CSF-ISF exchange through genetic deletion of 204 
AQP4 in the rodent brain. Hence, future studies are required to fully elucidate the relationship 205 
between para/perivascular fluid movement, CSF-ISF exchange and AQP4 expression15.  Furthermore, 206 
rates of glymphatic inflow have been linked to changes in extracellular space volume32 and central 207 
noradrenaline activity33 and how these factors may modulate measures of D* captured using the 208 
techniques presented here would be an interesting avenue of further study. Moreover, how the 209 
technique introduced here may be influenced by pathology is an important consideration.  For 210 
example, the composition of the CSF and PV fluid may change in disease, in turn altering the 211 
relaxation times of this compartment (for example the presence of iron could reduce PVS T2). Whilst 212 
this may not confound measures of D*, as relaxation time changes will be accounted for by the 213 
acquisition of a b0 image at identical TR and TE, this may change contrast between the PVS and 214 
surrounding tissue and potentially lessen the SNR of the measurements. MR relaxometry studies 215 
targeted to the normal and enlarged PVS may be an interesting avenue of future investigation 216 
leading to novel biomarkers of PVS composition.   Efforts are ongoing to investigate the sensitivity of 217 
the method to detect dysfunction of perivascular fluid movement associated with ageing and models 218 
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of pathological conditions, with the knowledge that clinical translation of this non-invasive approach 219 
may be practically achievable in the near future. 220 
 221 
Materials and Methods 222 
All experiments were performed in accordance with the UK Home Office’s Animals (Scientific 223 
Procedures) Act (1986). In total, 27 male Sprague Dawley rats were used in these experiments (n=10 224 
for multi-direction diffusion weighted imaging, n=6 for diffusion tensor imaging, n=5 for ECG gating, 225 
n=6 for dobutamine). Anaesthesia was induced using 4% isoflurane in 0.4L/min medical air and 226 
0.1L/min O2 and was maintained at 2% isoflurane whilst the animal was placed on a MRI compatible 227 
plastic probe. The head was secured using ear bars, a bite bar and a nose cone to minimise motion 228 
during the data acquisition. Once the probe was fixed in the scanner, isoflurane concentration was 229 
reduced to 1.75% in 0.4L/min medical air and 0.1L/min O2. Core body temperature was measured 230 
throughout using a rectal thermometer (Small Animal Instruments Inc.) and maintained at 37 ± 0.5oC 231 
using heated water tubing during the preparation and heated water tubing and warm air flow during 232 
the data acquisition period. Breathing rate was monitored throughout the acquisitions using a 233 
respiration pillow sensor (Small Animal Instruments Inc.). A scavenger pump was fixed inside the 234 
magnet bore to prevent build-up of isoflurane.  For the multiple direction diffusion weighting, power 235 
analysis based on pilot data was used to estimate the number of animal required to detect a 236 
significant difference in D* when motion probing gradients are applied parallel to the perivascular 237 
tracts relative to D* when motion probing gradients are applied perpendicular to the perivascular 238 
tracts (assuming a normal distribution). 239 
Magnetic Resonance Imaging 240 
All imaging was performed using a 9.4T VNMRS horizontal bore scanner (Agilent Inc., Palo Alto, CA). 241 
A 72mm inner diameter volume coil was used for RF transmission and signal was received using a 4 242 
channel array head coil (Rapid Biomedical). The imaging gradient hardware was calibrated using a 243 
custom designed structural phantom, as previously described34.  244 
A key aspect of the MRI sequence was the use of a long TE to attenuate the signal from the 245 
surrounding arterial blood and tissue (T2~ 30 and 38ms respectively at 9.4T 35) relative to the MRI 246 
signal from CSF in the subarachnoid space and fluid in perivascular channels (T2~111ms 36).  In order 247 
to achieve this, a fast spin echo (FSE) sequence was employed (180o refocusing pulses) with an echo 248 
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train length of 16 giving an effective echo time of 142ms (thus the ultra-long TE is compatible with a 249 
multiple echo train FSE readout for SNR efficiency). Therefore, at this echo time, the signal from the 250 
grey matter tissue, blood and CSF will have decayed to ~2%, 1% and 28% of the theoretical signal at 251 
TE=0 respectively.  In addition, the use of an ultra-long TE permits a long echo train per excitation 252 
(16 echoes) to increase the SNR efficiency of the acquisition (i.e. SNR per unit time). Finally, the use 253 
of a relatively long TR (5000ms), further weights the measured MRI signal from CSF/interstitial fluid 254 
relative to surrounding blood/tissue.  It should be noted that, as part of the FSE readout, phase 255 
encoding lines will be acquired at a range of different TEs and thus the eventual contrast in the 256 
image may deviate from that predicted by assuming a constant TEeff across all phase-encoding steps. 257 
Simulations (data not shown) indicate that this effect was minimal in the current study but future 258 
applications should consider this aspect of MRI image capture. 259 
In this study, four separate sets of experiments were performed, that can be divided into ‘multiple 260 
direction diffusion weighted imaging’ (n=10), ‘diffusion tensor imaging’ (n=6), ‘ECG-gating (n=5)’ and 261 
’Dobutamine (n=6)’. 262 
Multiple Direction Diffusion Weighted imaging (n=10) 263 
An axial slice was positioned at the ventral aspect of the brain at the level of the Circle of Willis (CoW 264 
- see Figure 1). A series of scout images were acquired with the slice orientation and position 265 
manually altered in an iterative manner in order that the perivascular space around the MCA could 266 
be optimally visualised.  267 
The angular orientation of the image was then changed so that the animals right perivascular tracts 268 
(surrounding the MCA in the axial slice) was aligned with the orientation of the frequency encoding 269 
(FE) imaging gradients. In doing so, the animals left perivascular tracts then become approximately 270 
aligned with the phase encoding (PE) imaging gradients (see Figure 2). This ensured that, when 271 
applying diffusion (or motion probing) gradients along the FE direction, the direction of diffusion 272 
weighting was parallel to the right perivascular tract and perpendicular to the left tract; and vice 273 
versa when applying diffusion gradients along the PE direction. As a result, the sensitivity for 274 
measuring differences in fluid movement along and across both tracts was maximised. 275 
A fast-spin echo imaging sequence was acquired with the following sequence parameters: TR = 5s, 276 
Echo Train Length = 16, effective TE = 142 ms, echo spacing = 10 ms, FOV = 25 x 25 mm, matrix size = 277 
128 x 128, slice thickness =0.8 mm or 1 mm, number of averages =12. A b=0 image was acquired 278 
with minimal diffusion weighting (b0) and then with separate acquisitions with the motion probing 279 
10 
 
gradients applied in three principle directions (X, Y, Z) with a b-value of 107 s/mm2  (δ = 5 ms, Δ = 280 
26ms , G = 4.2 G/cm).    281 
Regions of interest were manually drawn around the perivascular tracts surrounding the left and 282 
right MCA, as well as within the CSF of the subarachnoid space in the mid-section of the CoW from 283 
the b0 images. The subarachnoid space ROI was chosen because previous invasive measures have 284 
demonstrated rapid caudal-rostral CSF-tracer movement in this region28,37. As such, data from this 285 
ROI can provide a degree of validation for the technique if the directionality of fluid movement is 286 
found to be consistent with the established caudal-rostral fluid movement. The pseudo-diffusion 287 
coefficient (D*) was then calculated for each direction of the applied motion probing gradients using 288 
the following equation: 289 
S = S0 exp(-bD*) 290 
where S is the measured signal at b=107s/mm2, S0 is the signal taken from the b0 image. In this work 291 
we choose to report the exponential decay coefficient as the pseudo diffusion coefficient (D*) since 292 
this is analogous to the Intra-voxel Incoherent Motion (IVIM) literature where in-vivo D* estimates 293 
reflect an unknown contribution from relatively coherent flow in large and/or directionally ordered 294 
vessels and isotropic fluid motion derived from randomly orientated vessels within a MRI voxel.  295 
A paired t-test was applied to investigate i) if D* was greater when the motion probing gradient was 296 
applied parallel to the principle direction of the perivascular tracts, relative to application in each of 297 
the orthogonal planes for the left and right perivascular channels respectively; ii) if D* in the 298 
subarachnoid space ROI was significantly greater in the FE and PE directions than in the through 299 
plane slice selection direction. 300 
Diffusion Tensor Imaging (n=6) 301 
Images were acquired with no ‘diffusion weighting’ (b0) and then using motion probing gradients 302 
applied in 6 different directions (δ = 7.5 ms, Δ = 52ms, G = 1.5 G/cm, b value ~ 100 s/mm2) 303 
respectively with the following sequence parameters: TR = 5s, Echo Train Length = 16, effective TE = 304 
142 ms, FOV = 30 x 15 mm, matrix size = 128 x 64 , slice thickness = 1 mm, number of averages =24.    305 
Pseudo-Diffusion tensors were generated using a calculated b-matrix that incorporated the 306 
‘diffusion’ weighting introduced by the imaging gradients. As described above, ROIs were drawn 307 
around the perivascular tracts that surround the animal’s left and right MCA, as well as the CSF in 308 
the subarachnoid space that resides in the mid-section of the Circle of Willis. For visualisation 309 
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purposes,  pseudo-diffusion tensor ellipsoids were generated using the fanDTasia routines in Matlab 310 
38. For pseudo-diffusion tensor mapping, images were smoothed using an edge preserving filter and 311 
thresholded based on signal intensity, to remove signals that did not principally derive from fluid 312 
filled compartments and images were generated using the Explore DTI toolbox39. Maps were colour 313 
coded according to their principle orientation. In one animal, the diffusion tensor sequence was 314 
applied to the brain immediately post-mortem.  315 
ECG Gating (n=5) 316 
In these experiments, a three lead electrode was used to measure ECG signals in the bore of the 317 
magnet. The diffusion weighted sequence was acquired with the following parameters: TR = 5s, Echo 318 
Train Length = 16, effective TE = 142 ms, echo spacing = 10 ms, FOV = 25 x 25 mm, matrix size = 128 319 
x 128, slice thickness = 1 mm, number of averages =12, δ = 5 ms, Δ = 26ms , diffusion gradient 320 
amplitude = 2.3 G/cm, b value ~ 45 s/mm2, diffusion gradients applied in two directions (in plane, 321 
parallel to the PVS around the left and right MCA respectively).   322 
Image capture was gated to the ECG signal and image acquisition began either directly after the r-323 
wave or with an 80 ms delay. Given that the diffusion weighting is applied during the first echo time 324 
at 72ms, this results in a delay of 36ms from the r-wave to the centre of diffusion weighting (i.e the 325 
first 180o refocusing pulse) or 116ms with the additional 80ms delay. As Δ was 26ms in these 326 
acquisitions, the ‘diffusion weighting’ was therefore applied between 23 and 49ms from the r-wave 327 
and 103 and 129ms from the r-wave respectively.  Given previous recordings of pulse wave velocity 328 
in the mouse brain of 2.69 m/s 40 and given an approximate distance from the heart to the MCA of 329 
10cm in ~400g rats (together with the separation between adjacent r-waves to be ~150ms) we 330 
define the separate acquisitions to therefore take place during cerebral arterial pulsation or diastole.  331 
It should be noted that due to the ECG gating employed in these experiments, the TR will vary 332 
slightly between successive echo trains, but given the minimum TR was 5s and that the r-r interval in 333 
the rat is ~ 150ms, this should introduce relatively little variation into the measured MRI signal.  ROIs 334 
were drawn around the left and right PVS and within the mid-section of the subarachnoid space as 335 
before. In addition, ROIS were drawn within the 3rd ventricle to examine the r-wave delay 336 
dependence on measures of D* within ventricular CSF.  The average D* in the PVS (MPGs applied 337 
parallel and perpendicular to PVS orientation respectively) was taken for each rat and a paired t-test 338 
was used to investigate if D* (MPGs parallel to PVS orientation) was greater during arterial pulsation 339 
relative to diastole for each region. 340 
 341 
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Dobutamine (n=6) 342 
Data were acquired in 6 male Sprague Dawley rats using the identical MRI sequence approach 343 
described above (‘ECG gating’) but with no ECG gating. Dobutamine (n=3 subcutaneous bolus, 344 
2mg/kg 41 in saline ~0.6-0.8ml) or saline vehicle (n=3) was then delivered and the same acquisitions 345 
were performed after bolus infusion.  346 
Figure Legends 347 
Figure 1. A. Example b0 MRI image. The position and orientation of the imaging slice is adjusted to 348 
optimally visualize the perivascular space (PVS) around both branches of the MCA. Bright signal can 349 
be observed from fluid filled compartments: CSF in the subarachnoid space around the Circle of 350 
Willis (CoW); fluid in the perivascular space that surrounds the MCA;  the ventral aspect of the third 351 
ventricle.  B. Photograph of the ventral aspect of the rat brain surface illustrating a putative PVS 352 
surrounding the middle cerebral artery (MCA) (reproduced with permission from Lochhead et al., 353 
2015). 354 
Figure 2. A. Example bO and ‘diffusion weighted’ images acquired with the motion probing gradients 355 
applied in 3 orthogonal directions respectively.  B. The mean D* calculated within ROIs [see insert] in 356 
the right perivascular space (red), left perivascular space (blue), subarachnoid space (green) with the 357 
motion probing gradients applied in three orthogonal directions (+/- SEM). 358 
Figure 2 – figure supplement 1. The individual animal D* calculated within ROIs in the right 359 
perivascular space (A), left perivascular space (B), subarachnoid space (C) with the motion probing 360 
gradients applied in three orthogonal directions (x-axis). Each line represents an individual animal 361 
(n=10). 362 
Figure 3. A. bO image with ROIs in the right and left PVS and subarachnoid space highlighted in blue, 363 
red and green respectively. The mean pseudo-diffusion tensor ellipsoid within the subarachnoid 364 
space ROI (B) and right (C) and left (D) PVS respectively across the 6 rats. The pseudo-diffusion 365 
tensors for each individual animal are shown in Figure 3-figure supplement 1.  E. Example map of 366 
pseudo-diffusion tensor ellipsoids with corresponding b0 image (insert). 367 
Figure 3– figure supplement 1. D* tensors within the left and right perivascular space (PVS) and 368 
subarachnoid space ROIs for each of the individual subjects imaged in part ii). The corresponding D* 369 
tensor for the dead brain is also shown. 370 
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Figure 4. A. b0 image (first column) and D* maps during arterial pulsation (second and third column) 371 
and during diastole (fourth and fifth column) from a single animal [the white arrows represent the 372 
direction of the applied MPGs]. B. The mean D* during arterial pulsation and diastole respectively 373 
within the three ROIs for MPGs applied parallel (black line) and perpendicular to (grey dashed line) 374 
PVS orientation. C. The mean D* at baseline and after dobutamine (black line) or vehicle (grey 375 
dashed line) within the same ROIs (non-gated). 376 
Figure 4 – figure supplement 1. A. The individual animal D* during arterial pulsation and diastole 377 
respectively within the three ROIs for MPGs applied parallel (black line) and perpendicular to (grey 378 
dashed line) PVS orientation. B. The mean D* at baseline and after dobutamine (black line) or vehicle 379 
(grey dashed line) within the same ROIs (non-gated). Each line represents an individual animal. 380 
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arterial wall
A. Example b0 MRI image. The position and orientation of 
the imaging slice is adjusted to optimally visualize the 
perivascular space (PVS) around both branches of the MCA. 
Bright signal can be observed from fluid filled 
compartments: CSF in the subarachnoid space around the 
Circle of Willis (CoW); fluid in the perivascular space that 
surrounds the MCA;  the ventral aspect of the third 
ventricle. 
B. Photograph of the ventral aspect of the rat brain surface 
illustrating a putative PVS surrounding the middle cerebral 
artery (MCA) (reproduced with permission from Lochhead
et al., 2015). 
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A. Example bO and 
‘diffusion weighted’ 
images acquired with the 
motion probing gradients 
applied in 3 orthogonal 
directions respectively. 
B. The mean D* 
calculated within ROIs 
[see insert] in the right  
perivascular space (red), 
left perivascular space 
(blue), subarachnoid 
space (green) with the 
motion probing gradients 
applied in three 
orthogonal directions (+/-
SEM). 
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A. bO image with ROIs in the right and left PVS and subarachnoid space 
highlighted in blue, red and green respectively. The mean pseudo-diffusion tensor 
ellipsoid within the subarachnoid space ROI (B) and right (C) and left (D) PVS 
respectively across the 6 rats. The pseudo-diffusion tensors for each individual 
animal are shown in Figure 3-figure supplement 1.  E. Example map of pseudo-
diffusion tensor ellipsoids with corresponding b0 image (insert) 
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A. b0 image (first column) and D* maps during arterial pulsation (second and third column) and during diastole (fourth and fifth column) from a 
single animal [the white arrows represent the direction of the applied MPGs]. B. The mean D* during arterial pulsation and diastole respectively 
within the three ROIs for MPGs applied parallel (black line) and perpendicular to (grey dashed line) PVS orientation. C. The mean D* at baseline 
and after dobutamine (black line) or vehicle (grey dashed line) within the same ROIs (non-gated). 
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Figure 2 – figure supplement 1
The  individual animal D* calculated within ROIs in the right perivascular space (A), left perivascular space (B), 
subarachnoid space (C) with the motion probing gradients applied in three orthogonal directions (x-axis). Each 
line represents an individual animal (n=10). 
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Figure 3– figure supplement 1
D* tensors within the left and right perivascular space (PVS) and subarachnoid space ROIs for 
each of the individual subjects imaged in part ii). The corresponding D* tensor for the dead brain 
is also shown. 
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A. The individual animal D* during arterial pulsation and diastole respectively within the three ROIs for MPGs applied parallel (black 
line) and perpendicular to (grey dashed line) PVS orientation. B. The mean D* at baseline and after dobutamine (black line) or vehicle 
(grey dashed line) within the same ROIs (non-gated). Each line represents an individual animal.
